Stock listing
Bicara Therapeutics Inc.
Selected listing: BCAX · NASDAQ · USD · US
Bicara Therapeutics Inc. (NASDAQ:BCAX), Health Technology. Latest release Oct 5, 2026: Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing…
- Ticker
- NASDAQ:BCAX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Bicara Therapeutics Inc.
Bicara Therapeutics Inc. is a public company traded under the ticker BCAX in the American market. Bicara focuses on developing innovative therapies, leveraging its expertise to advance treatment options in the healthcare sector.
Latest news from Bicara Therapeutics Inc.
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 5, 2026
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
October 4, 2026
Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth
August 11, 2026
Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET
August 4, 2026
Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors
July 28, 2026
Events
Research Bicara Therapeutics Inc.
Bicara Therapeutics Inc. company profile
View the public company page for Bicara Therapeutics Inc. on 6ix.
Bicara Therapeutics Inc. news
Read company news and market updates connected to Bicara Therapeutics Inc..
Bicara Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Bicara Therapeutics Inc..